Detraining effects on musculoskeletal parameters in early-postmenopausal osteopenic women – 3-month follow-up of the randomized controlled ACTLIFE-study
Main Authors: | Wolfgang Kemmler, Simon von Stengel, Klaus Engelke |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Bone Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187221000863 |
Similar Items
-
Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT
by: Hettchen M, et al.
Published: (2021-01-01) -
Detraining Effects on Muscle Quality in Older Men with Osteosarcopenia. Follow-Up of the Randomized Controlled Franconian Osteopenia and Sarcopenia Trial (FrOST)
by: Mansour Ghasemikaram, et al.
Published: (2021-05-01) -
Changes in Body Composition and Cardiometabolic Health After Detraining in Older Men with Osteosarcopenia: 6-Month Follow-Up of the Randomized Controlled Franconian Osteopenia and Sarcopenia Trial (FrOST) Study
by: Kemmler W, et al.
Published: (2021-04-01) -
Whole-Body Electromyostimulation to Fight Osteopenia in Elderly Females: The Randomized Controlled Training and Electrostimulation Trial (TEST-III)
by: Simon von Stengel, et al.
Published: (2015-01-01) -
Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial
Published: (2012-09-01)